Results 31 to 40 of about 178,855,135 (215)

Novel modified quantitative index for cone-beam CT assessment of medication-related osteonecrosis of the jaw - comparative analysis with original index

Saudi Dental Journal, 2023
Purpose: The main research goal was to address the critical need for an objective and quantitative index to describe the nature and extent of radiographic features of medication-related osteonecrosis of the jaw (MRONJ) lesions and complement the ...
Ghaidaa Badabaan, Maxine Strickland, Steven R Singer, Adriana G. Creanga, Gayathri Subramanian   +4 more
doaj   +1 more source

Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis

, 2010
Bisphosphonates are the leading drugs for the treatment of osteoporosis. In ­randomized controlled trials (RCTs), alendronate, risedronate, and zoledronate have shown to reduce the risk of vertebral, nonvertebral, and hip fractures, whereas RCTs with ...
Graham Russell, Cooper, Cyrus, Ebetino, F. Hal, Cooper, C, Russell, RG, Pazianas, Michael, Ebetino, FH, Russell, R. Graham G., Pazianas, M   +8 more
core   +1 more source

Knowledge of Brazilian dentists about bisphosphonate-associated osteonecrosis of the jaw

Brazilian Dental Science
Osteonecrosis of the jaw associated with bisphosphonate use is a matter of utmost importance in clinical practice for the safe treatment of patients using this medication.
Thainara Alexia Marinho de Souza , Gabriela Ribeiro Zucco, Janete Dias Almeida   +2 more
doaj   +1 more source

Bisphosphonate-related osteonecrosis of the jaw: An enigma among medical practitioners

Indian Journal of Medical and Paediatric Oncology, 2019
Context: Owing to the increasing number of cancer cases, and introduction of newer drugs like bisphosphonates (BP) for the management of metastatic bone disease, complications such as bisphosphonate-related osteonecrosis of the jaw (BRONJ) have come into
Shalini Krishnan, Vijith Shetty, Jayarama Shetty, Gogineni Subhas Babu, T P Rajeev   +4 more
doaj   +1 more source

A Case Report of Ibandronic Acid Induced Non-Exposed BRONJ Involving the Maxillary Sinus

eJournal of Oral Maxillofacial Research, 2023
Background: The aim of this case report is to present an interesting case of bisphosphonate-related osteonecrosis of the jaw, involving the maxilla and the maxillary sinus, as a result of per os administration of ibandronic acid.
Ioannis Fotopoulos, Vasileios Zisis, Theodoros Lillis, Petros Mourouzis, Dimitrios Andreadis, Athanasios Poulopoulos, Nikolaos Dabarakis   +6 more
doaj   +1 more source

Intraosseous Squamous Cell Carcinoma Associated with Denosumab-Induced Osteonecrosis of the Jaw [PDF]

, 2021
Medication-related osteonecrosis of the jaw (MRONJ) has been associated with the use of different drugs administered in the treatment of malignant neoplasms or metastases and in antiresorptive therapies. Since 2010, denosumab, a monoclonal antibody whose
Carlos Navarro Cuéllar, Zamorano León, José Javier, Rodríguez Pérez, Irene, Bacián Martínez, Sandra, Navarro Vila, Carlos, Ignacio Navarro Cuéllar, Edurne Palacios Weiss, José Luis del Castillo Pardo de Vera, García-Hidalgo Alonso, María Isabel, Amo Fernández de Velasco, Álvaro del, Pujol Romanyá, Roser, Margarita Escrig de Teijeiro, Palacios Weiss, Edurne, Navarro Cuéllar, Carlos, Álvaro del Amo Fernández de Velasco, María Isabel García-Hidalgo Alonso, Sandra Bacián Martínez, José J. Zamorano-León, López Farre, Antonio José, Arturo Sánchez-Pérez, Roser Pujol Romanyá, Antonio López-Farré, Navarro Cuéllar, Ignacio, Escrig de Teijeiro, Margarita, Sánchez-Pérez, Arturo, Irene Rodríguez Pérez, Castillo Pardo de Vera, José Luis del, Carlos Navarro Vila   +27 more
core   +1 more source

Systemic Therapy Management Strategies for Early‐Stage Breast Cancer in Australia

Asia-Pacific Journal of Clinical Oncology, EarlyView.
Advances in systemic therapy for early‐stage breast cancer in Australia highlight genomic‐guided decisions, subtype‐specific strategies, and emerging targeted and immunotherapies, shaping personalized and de‐escalated treatment approaches. ABSTRACT Breast cancer is the most common cancer among Australian women, with early‐stage disease (Stages I, II ...
Nicholas Zdenkowski, Rachel Dear, Sanjeev Kumar, Hilary Martin, Dhanusha Sabanathan, Stephen J. Luen, Belinda Yeo   +6 more
wiley   +1 more source

Bisphosphonate-related osteonecrosis of the jaw complicated by Ludwig's angina [PDF]

, 2015
Ludwig's angina is a life-threatening cellulitis that involves the submandibular and sublingual spaces. It often occurs after an infection of the roots of the teeth.
Shen, Shu-Huei, Chu, Yum-Kung, Yang, Rong-Hsin, Li, Wing-Yin   +3 more
core   +1 more source

A maxillary reconstruction after osteonecrosis with surgical biomodels: A case report

Advances in Oral and Maxillofacial Surgery, 2021
Medication-related osteonecrosis of the jaw is a low prevalence condition in cancer patients which is mainly associated with bisphosphonates and other medication therapies, such as antiresorptive and antiangiogenic therapies.
Helena Polmann, Beatriz Helena Eger Schmitt, Roberta Aliny Santos Bendini, Pablo Cornelius Comelli Leite   +3 more
doaj   +1 more source

Bisphosphonate-associated osteonecrosis of the jaw: the rheumatologist's role.

Arthritis research & therapy, 2006
Several recent reports have described osteonecrosis of the jaws (ONJ) associated with the use of bisphosphonates. Rheumatologists treating bone diseases with bisphosphonate need, therefore, to be aware of this potential risk and plan the prophylaxis, early diagnosis and prevention of potential consequences.
F. Capsoni, M. Longhi, R. Weinstein
openaire   +2 more sources